Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study:
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
2015
|
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | Aus: Annals of the Rheumatic Diseases 74.1 (2015): S. 35-43. <http://ard.bmj.com/content/74/1/35> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. |
| Beschreibung: | 1 Online-Ressource |
| Format: | Langzeitarchivierung gewährleistet, LZA |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043905780 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161130s2015 gw |||| o||u| ||||||eng d | ||
| 015 | |a 16,O12 |2 dnb | ||
| 016 | 7 | |a 1119451124 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-78860 |2 urn | |
| 035 | |a (OCoLC)965688027 | ||
| 035 | |a (DE-599)DNB1119451124 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 082 | 0 | |a 610 |2 23 | |
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Huizinga, T. W. J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |c T. W. J. Huizinga, Philip G. Conaghan, Emilio Martin-Mola, Georg Schett, Howard Amital, Ricardo M. Xavier, Orrin Troum, Maher Aassi, Corrado Bernasconi, Maxime Dougados |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |c 2015 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Aus: Annals of the Rheumatic Diseases 74.1 (2015): S. 35-43. <http://ard.bmj.com/content/74/1/35> | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. | ||
| 500 | |a This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. | ||
| 538 | |a Langzeitarchivierung gewährleistet, LZA | ||
| 700 | 1 | |a Conaghan, Philip G. |e Verfasser |4 aut | |
| 700 | 1 | |a Martín-Mola, Emilio |e Verfasser |4 aut | |
| 700 | 1 | |a Schett, Georg |e Verfasser |4 aut | |
| 700 | 1 | |a Amital, Howard |e Verfasser |4 aut | |
| 700 | 1 | |a Xavier, Ricardo M. |e Verfasser |4 aut | |
| 700 | 1 | |a Troum, Orrin |e Verfasser |4 aut | |
| 700 | 1 | |a Aassi, Maher |e Verfasser |4 aut | |
| 700 | 1 | |a Bernasconi, Corrado |e Verfasser |4 aut | |
| 700 | 1 | |a Dougados, Maxime |e Verfasser |4 aut | |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-78860 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1119451124/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/7886 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029314921 | ||
Datensatz im Suchindex
| _version_ | 1804176813620985856 |
|---|---|
| any_adam_object | |
| author | Huizinga, T. W. J. Conaghan, Philip G. Martín-Mola, Emilio Schett, Georg Amital, Howard Xavier, Ricardo M. Troum, Orrin Aassi, Maher Bernasconi, Corrado Dougados, Maxime |
| author_facet | Huizinga, T. W. J. Conaghan, Philip G. Martín-Mola, Emilio Schett, Georg Amital, Howard Xavier, Ricardo M. Troum, Orrin Aassi, Maher Bernasconi, Corrado Dougados, Maxime |
| author_role | aut aut aut aut aut aut aut aut aut aut |
| author_sort | Huizinga, T. W. J. |
| author_variant | t w j h twj twjh p g c pg pgc e m m emm g s gs h a ha r m x rm rmx o t ot m a ma c b cb m d md |
| building | Verbundindex |
| bvnumber | BV043905780 |
| collection | ebook |
| ctrlnum | (OCoLC)965688027 (DE-599)DNB1119451124 |
| dewey-full | 610 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610 |
| dewey-search | 610 |
| dewey-sort | 3610 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02489nmm a2200517zc 4500</leader><controlfield tag="001">BV043905780</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161130s2015 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">16,O12</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1119451124</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-78860</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)965688027</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1119451124</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Huizinga, T. W. J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study</subfield><subfield code="c">T. W. J. Huizinga, Philip G. Conaghan, Emilio Martin-Mola, Georg Schett, Howard Amital, Ricardo M. Xavier, Orrin Troum, Maher Aassi, Corrado Bernasconi, Maxime Dougados</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Aus: Annals of the Rheumatic Diseases 74.1 (2015): S. 35-43. <http://ard.bmj.com/content/74/1/35></subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively.</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Langzeitarchivierung gewährleistet, LZA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Conaghan, Philip G.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martín-Mola, Emilio</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schett, Georg</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Amital, Howard</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xavier, Ricardo M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Troum, Orrin</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aassi, Maher</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bernasconi, Corrado</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dougados, Maxime</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-78860</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1119451124/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/7886</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029314921</subfield></datafield></record></collection> |
| id | DE-604.BV043905780 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:38:09Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029314921 |
| oclc_num | 965688027 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
| record_format | marc |
| spelling | Huizinga, T. W. J. Verfasser aut Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study T. W. J. Huizinga, Philip G. Conaghan, Emilio Martin-Mola, Georg Schett, Howard Amital, Ricardo M. Xavier, Orrin Troum, Maher Aassi, Corrado Bernasconi, Maxime Dougados Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) 2015 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Aus: Annals of the Rheumatic Diseases 74.1 (2015): S. 35-43. <http://ard.bmj.com/content/74/1/35> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. Langzeitarchivierung gewährleistet, LZA Conaghan, Philip G. Verfasser aut Martín-Mola, Emilio Verfasser aut Schett, Georg Verfasser aut Amital, Howard Verfasser aut Xavier, Ricardo M. Verfasser aut Troum, Orrin Verfasser aut Aassi, Maher Verfasser aut Bernasconi, Corrado Verfasser aut Dougados, Maxime Verfasser aut https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-78860 Resolving-System kostenfrei Volltext http://d-nb.info/1119451124/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/7886 Verlag kostenfrei Volltext |
| spellingShingle | Huizinga, T. W. J. Conaghan, Philip G. Martín-Mola, Emilio Schett, Georg Amital, Howard Xavier, Ricardo M. Troum, Orrin Aassi, Maher Bernasconi, Corrado Dougados, Maxime Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |
| title | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |
| title_auth | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |
| title_exact_search | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |
| title_full | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study T. W. J. Huizinga, Philip G. Conaghan, Emilio Martin-Mola, Georg Schett, Howard Amital, Ricardo M. Xavier, Orrin Troum, Maher Aassi, Corrado Bernasconi, Maxime Dougados |
| title_fullStr | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study T. W. J. Huizinga, Philip G. Conaghan, Emilio Martin-Mola, Georg Schett, Howard Amital, Ricardo M. Xavier, Orrin Troum, Maher Aassi, Corrado Bernasconi, Maxime Dougados |
| title_full_unstemmed | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study T. W. J. Huizinga, Philip G. Conaghan, Emilio Martin-Mola, Georg Schett, Howard Amital, Ricardo M. Xavier, Orrin Troum, Maher Aassi, Corrado Bernasconi, Maxime Dougados |
| title_short | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |
| title_sort | clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the act ray study |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-78860 http://d-nb.info/1119451124/34 https://open.fau.de/handle/openfau/7886 |
| work_keys_str_mv | AT huizingatwj clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT conaghanphilipg clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT martinmolaemilio clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT schettgeorg clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT amitalhoward clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT xavierricardom clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT troumorrin clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT aassimaher clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT bernasconicorrado clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy AT dougadosmaxime clinicalandradiographicoutcomesat2yearsandtheeffectoftocilizumabdiscontinuationfollowingsustainedremissioninthesecondandthirdyearoftheactraystudy |